By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Where Great Emphasis is Put on Research.

Medical University of Vienna: New therapy option doubles the life span of B-cell lymphoma patients

infusion © pixabay

That is the main finding of the multi-center JULIET study, in which researchers from the Comprehensive Cancer Centre (CCC) of the Medical University of Vienna and Vienna General Hospital participated. In CAR-T cell therapy, previously modified T-cells recognize a specific protein on the surface of the tumor. This in turn triggers destruction of the tumor cells. This introduces a new option for treating such patients. This is because the two-year survival rate following standard treatment is only 20 percent, whereas, with CAR-T cell therapy, overall survival has doubled to 40%. The results of this study were published in the New England Journal of Medicine.

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • Ukrainian-Austrian Business Forum

    27.4.2021/ 14.00 (CET) , Online Conference

  • Meet us @ Open Vienna - A Thriving Startup Ecosystem

    28.04.2021/ 9.15 am - 1.30 pm (CET), Online Conference

Austria Map

Find the perfect location for your company

Vienna is a beautiful city and a natural place to be for Trask. We are happy that we can introduce our great technology expertise together with revolutionary ready-to-use solutions to Austrian banks. And thanks to the cooperation with ABA everything is a bit easier.

Daniel Pecina, CEO Trask Austria GmbH

trask logo
More testimonials

news from the business location Austria

Medical University of Vienna and Vienna General Hospital: Expertise for lung transplants in cases of COVID-19

In May 2020, a team led by thoracic surgeon Konrad Hoetzenecker of the Department of Surgery of the Medical University of Vienna (MedUni Vienna) and Vienna General Hospital performed a lung transplant on a 44-year-old patient who had been seriously ill with COVID-19, making her the first patient in Europe to receive a lung transplant for this indication.

Shared Mobility in Austria!

"A green planet with mobility from everyone, for everyone" has continuously been the motto of GO Sharing.

More news All blog posts